Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126102141 | 12610214 | 1 | I | 20160708 | 20160720 | 20160801 | 20160801 | EXP | GB-MHRA-EYC 00142443 | GB-MYLANLABS-2016M1030189 | MYLAN | 0.00 | Y | 0.00000 | 20160801 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126102141 | 12610214 | 1 | PS | LORATADINE. | LORATADINE | 1 | UNK | U | U | 76154 | |||||||||
| 126102141 | 12610214 | 2 | SS | CHLORHEXIDINE GLUCONATE. | CHLORHEXIDINE GLUCONATE | 1 | Oral | 10 ML, BID | 20 | ML | Y | U | 1066LE0106 | 0 | 10 | ML | BID | ||
| 126102141 | 12610214 | 3 | SS | CYCLIZINE | CYCLIZINE | 1 | Intramuscular | UNK | U | U | 0 | ||||||||
| 126102141 | 12610214 | 4 | SS | DIHYDROCODEINE | DIHYDROCODEINE | 1 | UNK | U | U | 0 | |||||||||
| 126102141 | 12610214 | 5 | SS | ORAMORPH | MORPHINE SULFATE | 1 | UNK | U | U | 0 | |||||||||
| 126102141 | 12610214 | 6 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | UNK | U | U | 0 | |||||||||
| 126102141 | 12610214 | 7 | SS | SALBUTAMOL | ALBUTEROL | 1 | Respiratory (inhalation) | UNK | U | U | 0 | ||||||||
| 126102141 | 12610214 | 8 | SS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | UNK | U | U | 0 | ||||||||
| 126102141 | 12610214 | 9 | SS | LYRICA | PREGABALIN | 1 | UNK (150MG AND 300MG) | U | U | 0 | |||||||||
| 126102141 | 12610214 | 10 | C | ADCAL D3 | CALCIUM CARBONATECHOLECALCIFEROL | 1 | UNK | U | 0 | ||||||||||
| 126102141 | 12610214 | 11 | C | ALENDRONIC ACID | ALENDRONIC ACID | 1 | UNK | U | 0 | ||||||||||
| 126102141 | 12610214 | 12 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | UNK | U | 0 | ||||||||||
| 126102141 | 12610214 | 13 | C | COSMOCOL | 2 | UNK | U | 0 | |||||||||||
| 126102141 | 12610214 | 14 | C | LACTULOSE. | LACTULOSE | 1 | UNK | U | 0 | ||||||||||
| 126102141 | 12610214 | 15 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | UNK | U | 0 | ||||||||||
| 126102141 | 12610214 | 16 | C | PHENOXYMETHYLPENICILLIN | PENICILLIN V | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126102141 | 12610214 | 2 | Mouth ulceration |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126102141 | 12610214 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126102141 | 12610214 | Asthma | |
| 126102141 | 12610214 | Drug interaction | |
| 126102141 | 12610214 | Feeling abnormal | |
| 126102141 | 12610214 | Feeling drunk | |
| 126102141 | 12610214 | Oral discomfort | |
| 126102141 | 12610214 | Oxygen saturation decreased | |
| 126102141 | 12610214 | Swelling face |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126102141 | 12610214 | 2 | 20160708 | 20160708 | 0 |